-
A COMPREHENSIVE GLOBAL SYSTEMATIC LITERATURE REVIEW OF REAL-WORLD EVIDENCE OF RELAPSED/REFRACTORY AND POST-BRUTON TYROSINE KINASE INHIBITOR MANTLE CELL LYMPHOMA
Mar 18, 2026, 21:38 PM -
EPIDEMIOLOGY AND FUTURE BURDEN OF TRANSTHYRETIN AMYLOID CARDIOMYOPATHY (ATTR-CM) AMONG ADULTS IN THE UNITED STATES: A SYSTEMATIC REVIEW
Mar 18, 2026, 21:38 PM -
BIAS GAPS IN REAL-WORLD DATA-BASED ECONOMIC EVALUATIONS: UNDERREPORTING, WEAK CONTROL, AND THE NEED TO UPGRADE PROPENSITY SCORE PRACTICE
Mar 18, 2026, 21:38 PM -
HOSPITAL AND ICU ADMISSION FORECASTS FOR LRTIS AND COPD IN SWITZERLAND THROUGH 2035: PROJECTING DEMOGRAPHIC EFFECTS ON HEALTHCARE RESOURCE UTILISATION, INPATIENT EXPENDITURES, AND GREENHOUSE GAS EMISSIONS (BRONCH-2035)
Mar 18, 2026, 21:38 PM -
DOES YOUR 1-MILLION-MEMBER COHORT TELL THE WHOLE STORY? RETHINKING ELIGIBLE POPULATION ESTIMATION IN CHRONIC DISEASE BUDGET IMPACT ANALYSES IN THE US
Mar 18, 2026, 21:38 PM -
EVALUATION OF MACHINE LEARNING-ASSISTED RISK OF BIAS ASSESSMENTS FOR SUPPORTING SYSTEMATIC REVIEWS. A CASE STUDY OF A REVIEW IN MOVEMENT DISORDERS
Mar 18, 2026, 21:38 PM -
GOAL INVENTORIES IN STANDARDIZED IMPLEMENTATION OF PERSONALIZED OUTCOME ASSESSMENTS USING GOAL ATTAINMENT SCALING: A LANDSCAPE ANALYSIS
Mar 18, 2026, 21:38 PM -
MULTI-CRITERIA DECISION ANALYSIS IN HEALTH INTERVENTION PRIORITY SETTING FOR UNIVERSAL HEALTH COVERAGE IN KENYA: AN EXPLORATORY STUDY
Mar 18, 2026, 21:38 PM -
EVALUATION OF OFF-THE-SHELF AGENT-BASED AI TOOL CLAUDE CODE FOR RAPID REPLICATION OF A PUBLISHED COST-EFFECTIVENESS MODEL
Mar 18, 2026, 21:38 PM -
DEVELOPMENT OF A PROFESSIONAL FRAMEWORK FOR MARKET ACCESS WITHIN THE PHARMACEUTICAL INDUSTRY: A MULTI-METHODS STUDY
Mar 18, 2026, 21:38 PM -
EVIDENCE-BASED BENEFIT-RISK ASSESSMENT OF THE RSVPREF VACCINE IN ADULTS AGED =60 YEARS
Mar 18, 2026, 21:38 PM -
EARLY TOXICITIES AND ECONOMIC BURDEN OF CAR-T THERAPY IN THE UNITED STATES: A RETROSPECTIVE COHORT STUDY OF ICANS AND CRS USING OPTUM DATA
Mar 18, 2026, 21:38 PM -
UNMET MEDICAL NEED AND BURDEN OF OBESITY ON PATIENTS, PAYERS, AND HEALTH SYSTEMS IN CANADA, THE USA, AND ENGLAND
Mar 18, 2026, 21:38 PM -
WHY AI PROOF-OF-CONCEPTS DO NOT NECESSARILY PROVE ANYTHING: JOURNEY FROM POC TO PRODUCT
Mar 18, 2026, 21:38 PM -
THE UNINTENDED CONSEQUENCES OF THE INFLATION REDUCTION ACT ON BIOSIMILAR MARKET INCENTIVES AND MEDICARE SAVINGS
Mar 18, 2026, 21:38 PM -
BEYOND THE HEALTH SECTOR: ESTIMATING THE SOCIETAL AND FISCAL IMPACT OF PRIMARY BILIARY CHOLANGITIS IN THE UNITED STATES
Mar 18, 2026, 21:38 PM -
A PORTFOLIO MODELING FRAMEWORK FOR HEOR DECISION MAKING
Mar 18, 2026, 21:38 PM -
REAL-WORLD TREATMENT PATTERNS, OUTCOMES, AND RESOURCE UTILIZATION IN US ADULTS WITH NF1-PN
Mar 18, 2026, 21:38 PM -
HISTORIC PRICE DIFFERENTIALS AND MOST-FAVORED NATION PRESCRIPTION DRUG PRICING POLICY IMPACT: SCENARIO ANALYSIS USING POLI DATA ACROSS EIGHT GLOBAL MARKETS
Mar 18, 2026, 21:38 PM -
A MIXED-METHODS STUDY TO EXPLORE THE HEALTH-RELATED QUALITY OF LIFE IMPACT ON CAREGIVERS OF CHILDREN WITH HEREDITARY ANGIOEDEMA
Mar 18, 2026, 21:38 PM
